<--- Back to Details
First PageDocument Content
Biology / Interferon beta-1a / Pfizer / Anatomy / Interferon beta-1b / Autoimmune diseases / Neurological disorders / Therapies under investigation for multiple sclerosis / Treatment of multiple sclerosis / Multiple sclerosis / Cytokines / Immune system
Date: 2013-12-04 21:15:58
Biology
Interferon beta-1a
Pfizer
Anatomy
Interferon beta-1b
Autoimmune diseases
Neurological disorders
Therapies under investigation for multiple sclerosis
Treatment of multiple sclerosis
Multiple sclerosis
Cytokines
Immune system

Oral Oncology Referral Form

Add to Reading List

Source URL: www.nhhealthyfamilies.com

Download Document from Source Website

File Size: 56,65 KB

Share Document on Facebook

Similar Documents

Quarterly newsletter of the MS Trust  Open Door MayAlso in this issue

Quarterly newsletter of the MS Trust Open Door MayAlso in this issue

DocID: 1aIBR - View Document

Microsoft Word - stc_information_pack

Microsoft Word - stc_information_pack

DocID: 13Q2D - View Document

Treatments for MS: TECFIDERA® (dimethyl fumarate) There are currently nine disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity i

Treatments for MS: TECFIDERA® (dimethyl fumarate) There are currently nine disease-modifying therapies approved for people with MS in Australia. These therapies, called immunotherapies, work to reduce disease activity i

DocID: 10jxE - View Document

Treatments for MS: Gilenya ® (fingolimod)  There are currently several disease-modifying therapies approved for people with MS in

Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in

DocID: Xydz - View Document

Treatments for MS: Aubagio ® (Teriflunomide)  There are currently nine disease-modifying therapies approved for people with MS in

Treatments for MS: Aubagio ® (Teriflunomide) There are currently nine disease-modifying therapies approved for people with MS in

DocID: Wu9v - View Document